BioNTech SE - ADR vs Public Storage — how do they compare? BioNTech SE - ADR trades at $92.84 (market cap $23.31B), while Public Storage trades at $325 (market cap $60.71B). The key difference: Public Storage is far larger — about 2.6× BioNTech SE - ADR's market cap, and Public Storage pays a 3.69% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | PSA | |
|---|---|---|
Market Cap | $23.31B | $60.71B |
Sector | Health | Real Estate |
52-Week High | $119.34 | $330.47 |
52-Week Low | $83.89 | $258.44 |
Enterprise Value | $6.60B | $74.98B |
Dividend Yield | — | 3.69% |
Signals from Pluang's Aura AI — not financial advice
BioNTech (BNTX) trades at $92.80, down 0.93% on the day, reflecting ongoing pressure from declining COVID-19 vaccine revenue. The stock shows a bullish technical signal from moving averages but faces fundamental headwinds with a net loss of $1.14 billion in 2025 and negative profit margins. Recent Q2 2026 earnings missed expectations, and the company lowered its full-year sales outlook due to soft vaccine demand. Analyst consensus remains strongly bullish with a $121 price target, betting on the long-term potential of its oncology pipeline.
The investment case hinges on BioNTech's transition from COVID-19 vaccines to its deep oncology pipeline, valued near zero given its cash-rich balance sheet. Near-term risks include persistent earnings losses and volatile vaccine revenue, but the company's strong liquidity position and 14 pivotal clinical trials offer substantial upside if pipeline successes materialize. Investors are essentially getting the oncology assets for free, but execution risk is high.
Public Storage (PSA) trades at $325.71, down 0.82% on the day, with a bullish technical outlook supported by moving averages. The REIT maintains strong profitability with 41.8% net income margin and has beaten earnings estimates for three consecutive quarters. Recent developments include the completed acquisition of National Storage Affiliates and consistent $3.00 quarterly dividends, positioning the company for growth through expansion and operational efficiency.
PSA presents a mixed investment case with premium valuation metrics (P/E 31.02) offset by strong fundamentals and growth initiatives. The consensus price target of $333.88 suggests modest upside potential, though elevated P/E and P/B ratios warrant caution. Key risks include interest rate sensitivity and integration challenges from recent acquisitions, while the stable dividend and expansion into Canada provide growth catalysts.
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →